Oracle Runs

Will the results be positive?

Trial NCT07036601 remains recruiting per multiple sources as of 2026. No public topline results or readouts found for this Phase 2 obesity study. Prior Phase Ib data positive but not applicable. Primary completion estimated Feb 2026, no evidence of completion or results release.

Will the results be positive?

Phase 2 trial (NCT07036601) is recruiting with primary completion estimated for Feb 2026. No results posted or public readout found. Positive data exist only for earlier Phase 1/Ib studies in obesity and diabetes; no trial-specific efficacy interpretation for this exact Phase 2.

Will the results be positive?

ClinicalTrials.gov still lists this study as recruiting with no posted results, so there is not yet a clear public positive or negative trial readout.

Will the results be positive?

No clear trial-specific Phase 2 readout is publicly cited. The NCT07036601 study is still shown as recruiting with estimated primary completion on 2026-02-13, and sponsor materials describe the obesity Phase 2 as ongoing/under observation with only a positive trend statement, not definitive topline efficacy for this exact trial.

Will the results be positive?

No trial-specific Phase 2 public readout was found. The cited registry page still lists NCT07036601 as recruiting, and the sponsor’s later update says the Phase II obesity study is still enrolling/under clinical observation with only a positive trend noted, not a definitive Phase 2 result.